FCM regimen

Revision as of 12:54, 17 March 2015 by Aparna Vuppala (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for FCM regimen

Articles

Most recent articles on FCM regimen

Most cited articles on FCM regimen

Review articles on FCM regimen

Articles on FCM regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on FCM regimen

Images of FCM regimen

Photos of FCM regimen

Podcasts & MP3s on FCM regimen

Videos on FCM regimen

Evidence Based Medicine

Cochrane Collaboration on FCM regimen

Bandolier on FCM regimen

TRIP on FCM regimen

Clinical Trials

Ongoing Trials on FCM regimen at Clinical Trials.gov

Trial results on FCM regimen

Clinical Trials on FCM regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on FCM regimen

NICE Guidance on FCM regimen

NHS PRODIGY Guidance

FDA on FCM regimen

CDC on FCM regimen

Books

Books on FCM regimen

News

FCM regimen in the news

Be alerted to news on FCM regimen

News trends on FCM regimen

Commentary

Blogs on FCM regimen

Definitions

Definitions of FCM regimen

Patient Resources / Community

Patient resources on FCM regimen

Discussion groups on FCM regimen

Patient Handouts on FCM regimen

Directions to Hospitals Treating FCM regimen

Risk calculators and risk factors for FCM regimen

Healthcare Provider Resources

Symptoms of FCM regimen

Causes & Risk Factors for FCM regimen

Diagnostic studies for FCM regimen

Treatment of FCM regimen

Continuing Medical Education (CME)

CME Programs on FCM regimen

International

FCM regimen en Espanol

FCM regimen en Francais

Business

FCM regimen in the Marketplace

Patents on FCM regimen

Experimental / Informatics

List of terms related to FCM regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:FCMR Regimen; R-FCM Regimen; Rituximab-Fludarabine-Cyclophosphamide-Mitoxantrone Regimen

Overview

FCM regimen refers to a regimen consisting of fludarabine, cyclophosphamide, mitoxantrone used to treat indolent non-Hodgkin's lymphoma and relapsed or refractory mantle cell lymphoma.[1]and along with rituximab for the treatment of CLL[2]

Regimen

FFludarabine

CCyclophosphamide

MMitoxantrone

Indications

References

  1. "NCI Thesaurus".
  2. 2.0 2.1 Faderl S, Wierda W, O'Brien S, Ferrajoli A, Lerner S, Keating MJ (2010). "Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years". Leuk Res. 34 (3): 284–8. doi:10.1016/j.leukres.2009.07.008. PMID 19646755.
  3. "NCI Thesaurus".